1. Home
  2. OCUL vs CEPU Comparison

OCUL vs CEPU Comparison

Compare OCUL & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • CEPU
  • Stock Information
  • Founded
  • OCUL 2006
  • CEPU 1989
  • Country
  • OCUL United States
  • CEPU Argentina
  • Employees
  • OCUL N/A
  • CEPU N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • CEPU Electric Utilities: Central
  • Sector
  • OCUL Health Care
  • CEPU Utilities
  • Exchange
  • OCUL Nasdaq
  • CEPU Nasdaq
  • Market Cap
  • OCUL 1.8B
  • CEPU 1.7B
  • IPO Year
  • OCUL 2014
  • CEPU 2018
  • Fundamental
  • Price
  • OCUL $13.60
  • CEPU $10.11
  • Analyst Decision
  • OCUL Strong Buy
  • CEPU Hold
  • Analyst Count
  • OCUL 6
  • CEPU 1
  • Target Price
  • OCUL $17.20
  • CEPU $12.00
  • AVG Volume (30 Days)
  • OCUL 2.2M
  • CEPU 255.2K
  • Earning Date
  • OCUL 08-05-2025
  • CEPU 08-11-2025
  • Dividend Yield
  • OCUL N/A
  • CEPU 3.06%
  • EPS Growth
  • OCUL N/A
  • CEPU N/A
  • EPS
  • OCUL N/A
  • CEPU 0.12
  • Revenue
  • OCUL $56,664,000.00
  • CEPU $628,806,380.00
  • Revenue This Year
  • OCUL N/A
  • CEPU $11.09
  • Revenue Next Year
  • OCUL $18.87
  • CEPU $10.25
  • P/E Ratio
  • OCUL N/A
  • CEPU $10.60
  • Revenue Growth
  • OCUL N/A
  • CEPU N/A
  • 52 Week Low
  • OCUL $5.79
  • CEPU $8.65
  • 52 Week High
  • OCUL $13.82
  • CEPU $16.60
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 68.16
  • CEPU 35.65
  • Support Level
  • OCUL $12.41
  • CEPU $9.97
  • Resistance Level
  • OCUL $12.49
  • CEPU $10.66
  • Average True Range (ATR)
  • OCUL 0.56
  • CEPU 0.55
  • MACD
  • OCUL 0.04
  • CEPU -0.10
  • Stochastic Oscillator
  • OCUL 88.48
  • CEPU 6.41

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About CEPU Central Puerto S.A. (each represents ten)

Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.

Share on Social Networks: